SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-03-026441
Filing Date
2003-11-14
Accepted
2003-11-14 10:32:41
Documents
6
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a03-5313_110q.htm 10-Q 555505
3 EX-10.41 a03-5313_1ex10d41.htm EX-10.41 54024
4 EX-31.1 a03-5313_1ex31d1.htm EX-31.1 11936
5 EX-31.2 a03-5313_1ex31d2.htm EX-31.2 12055
6 EX-32.1 a03-5313_1ex32d1.htm EX-32.1 4670
7 EX-32.2 a03-5313_1ex32d2.htm EX-32.2 5142
  Complete submission text file 0001104659-03-026441.txt   645296
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21481 | Film No.: 031000943
SIC: 2836 Biological Products, (No Diagnostic Substances)